Shares of NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) were down 17.8% during trading on Tuesday . The stock traded as low as $0.21 and last traded at $0.21. Approximately 3,523 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 811,522 shares. The stock had previously closed at $0.25.
NexImmune Price Performance
The company’s fifty day moving average price is $0.26 and its two-hundred day moving average price is $1.46. The firm has a market cap of $337,597.64, a PE ratio of -0.01 and a beta of 1.66.
NexImmune Company Profile
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Read More
- Five stocks we like better than NexImmune
- Differences Between Momentum Investing and Long Term Investing
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Why Are Stock Sectors Important to Successful Investing?
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Canadian Penny Stocks: Can They Make You Rich?
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
